Title : Discovery of bioavailable inhibitors of secretory phospholipase A2.

Pub. Date : 1998

PMID : 9760691






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Compounds containing fluorine in the terminal positions of the alkyl chain retained sPLA2 inhibitory activity and also possessed improved in vitro metabolic stability and pharmacokinetic parameters relative to nonfluorinated inhibitors in this series. Fluorine phospholipase A2 group IIA Rattus norvegicus
2 In fact, the results for GW 9624 and GW 8219 suggested that factors in addition to potency of sPLA2 inhibition and metabolism affect the observed in vivo activity. glycyltryptophan phospholipase A2 group IIA Rattus norvegicus
3 In fact, the results for GW 9624 and GW 8219 suggested that factors in addition to potency of sPLA2 inhibition and metabolism affect the observed in vivo activity. glycyltryptophan phospholipase A2 group IIA Rattus norvegicus